Cite
Palve V, Knezevic CE, Bejan DS, et al. The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors. Cell Chem Biol. 2021;doi: 10.1016/j.chembiol.2021.07.008.
Palve, V., Knezevic, C. E., Bejan, D. S., Luo, Y., Li, X., Novakova, S., Welsh, E. A., Fang, B., Kinose, F., Haura, E. B., Monteiro, A. N., Koomen, J. M., Cohen, M. S., Lawrence, H. R., & Rix, U. (2021). The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors. Cell chemical biology, . https://doi.org/10.1016/j.chembiol.2021.07.008
Palve, Vinayak, et al. "The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors." Cell chemical biology vol. (2021). doi: https://doi.org/10.1016/j.chembiol.2021.07.008
Palve V, Knezevic CE, Bejan DS, Luo Y, Li X, Novakova S, Welsh EA, Fang B, Kinose F, Haura EB, Monteiro AN, Koomen JM, Cohen MS, Lawrence HR, Rix U. The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors. Cell Chem Biol. 2021 Jul 22; doi: 10.1016/j.chembiol.2021.07.008. Epub 2021 Jul 22. PMID: 34329582.
Copy
Download .nbib